A John Kanellopoulos. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultCombined Modality TherapyCorneal Diseases/drug therapyCorneal Diseases/etiologyCorneal Diseases/surgeryCorneal Diseases/therapyCorneal TopographyDevice RemovalDilatation, Pathologic/drug therapyDilatation, Pathologic/etiologyDilatation, Pathologic/surgeryDilatation, Pathologic/therapyHumansKeratomileusis, Laser In SituLasers, ExcimerMalePhotochemotherapy/methodsPhotorefractive Keratectomy/methodsPhotosensitizing Agents/therapeutic usePostoperative ComplicationsProstheses and ImplantsProsthesis ImplantationReoperationRiboflavin/therapeutic useTreatment FailureUltraviolet Rays
Substances: See more » Photosensitizing AgentsRiboflavin
Year: 2007 PMID: 17544782 DOI: 10.1016/j.ophtha.2007.03.041
Source DB: PubMed Journal: Ophthalmology ISSN: 0161-6420 Impact factor: 12.079